Hepion Pharmaceuticals, Inc.
New Filing
CIK: 0001583771·Biotechnology·DELAWARE·Filed: Apr 22, 2026
Total Offering
$700,000
Amount Sold
$700,000
Investors
11
First Sale
Apr 21, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Gary Stetz | |
| Vincent LoPriore | |
| Sireesh Appajosyula | |
| Chase LoPriore | |
| Michael Purcell | |
| Timothy Block |
Company
SEC Filing
0001493152-26-018593
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free